We speculate that IL-17-induced CCL20 production in the tumor microenvironment may act in an autocrine manner to stimulate tumor cell growth and in a paracrine manner to enhance the tumor-associated inflammatory response. This evidence concerns the gene CCL20 and neoplasm.